Evidence map›Paper›PMID 21406316›Full record

ArticleAddictive behaviors2011

Black and White adults' perspectives on the genetics of nicotine addiction susceptibility.

Elyse R Park, Susan Kleimann, Emily J Youatt, Abigail Lockhart, Eric G Campbell, Douglas E Levy, Chanita Hughes Halbert, Erin Schmieder, Rasika Krishna, Alexandra E Shields

Registry-linked trialOpen access · greenAbstract readMulticenter Study
In one paragraph

Article in Addictive behaviors, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01780038 (Smokers' Response to Nicotine Dependence Genotyping), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01780038 nacompletednot on this mapstarted 2012, after this paper: background citation

Smokers' Response to Nicotine Dependence Genotyping

TypeinterventionalSponsorUniversity of NebraskaRan2012 to 2013Enrolled24ConditionsCigarette Smoking, Nicotine DependenceArmsReceipt of Genetic Results, No results given
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Pharmacogenetic smoking cessation intervention in a health care setting: a pilot feasibility study.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2013
    Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Elyse R ParkHarvard/MGH Center on Genomics, Vulnerable Populations, and Health Disparities, Boston, MA 02114, United States. epark@partners.org
Susan Kleimann
Emily J Youatt
Abigail Lockhart
Eric G Campbell
Douglas E Levy
Chanita Hughes Halbert
Erin Schmieder
Rasika Krishna
Alexandra E Shields
Harvard University · USDana-Farber/Harvard Cancer Center · USUniversity of Pennsylvania · US

Funding

Lay Understanding of Race, Addiction and GeneticsR01HG003475 · NHGRI · MASSACHUSETTS GENERAL HOSPITAL · PI SHIELDS, ALEXANDRA E · 2006 to 2011
$2.0M
NHGRI NIH HHS R01 HG003475NHGRI NIH HHS R01 HG003475-01A1
6 · The paper itself

Abstract

aimsEmerging research may soon lead to improved quit rates via genetically-tailored smoking cessation treatment. The purpose of this study was to explore individuals' beliefs and attitudes about genetic testing in this context, and how these may differ across racial groups.

designTwo site qualitative study.

methodsEleven focus groups were conducted in 2007 with 51 Black and 55 White adult participants in Montgomery, AL and Baltimore, MD. MEASUREMENTS: Questions were asked about smoking as an addiction, the role of genetics in nicotine addiction susceptibility, and undergoing genetic testing to receive tailored smoking cessation treatment. Data were analyzed using content analysis.

findingsMost participants believed that smoking was an addiction yet were unwilling to endorse the notion that genetics played a role in nicotine addiction susceptibility. However, 91% of White participants and 62% of Black participants indicated that they would likely take a genetic test that would match them to their optimal smoking cessation treatment. The primary potential benefit was a vague sense that additional knowledge about oneself would be of value. Primary barriers included disinterest and skepticism about the test, unwillingness to believe that genetics played a role in nicotine addiction or treatment response, and concerns about psychological consequences.

conclusionsThe majority of participants, particularly Black participants, did not believe that genetics played a significant role in nicotine addiction susceptibility but were willing to undergo genetic testing. Participants identified some benefit to tailoring smoking treatment by genotype. However, participants also expressed skepticism about the test and concerns about its consequences; these issues would need to be addressed in the clinical encounter.

Indexed as

AdultAgedAged, 80 and overAlabamaAttitude to HealthBehavior, AddictiveBlack or African AmericanBlack PeopleFemaleGenetic Predisposition to DiseaseHumansMaleMarylandMiddle AgedQualitative ResearchSmoking

Identifiers

PMID21406316
PMCPMC3732108
OpenAlexW2043768740

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.